R&D | May 02, 2026
Thermo Fisher opens flagship US Bioprocess Design Center in Massachusetts
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities
Move brings together AstraZeneca and Alexion colleagues in a purpose-built facility in Kendall Square, Cambridge, MA, a world-leading life sciences hub
The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
_256_384.jpg)
The approval makes Cipla’s product the first AB-rated generic therapeutic equivalent of Ventolin HFA
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
The decision marks a pivotal moment for the Massachusetts-based biotech giant
Investment marks continued progress against AbbVie's $100 billion commitment to U.S. R&D and capital investments, including manufacturing, over the next decade
Subscribe To Our Newsletter & Stay Updated
